TARO — Taro Pharmaceutical Industries Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,109 | 1,024 | 821 | 850 | 879 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 264 | 254 | 293 | 248 | 219 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1,533 | 1,471 | 1,338 | 1,336 | 1,303 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 212 | 208 | 205 | 194 | 218 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,341 | 2,407 | 2,176 | 2,136 | 2,162 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 223 | 676 | 432 | 386 | 361 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 237 | 703 | 465 | 405 | 369 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,104 | 1,704 | 1,711 | 1,731 | 1,793 |
Total Liabilities & Shareholders' Equity | 2,341 | 2,407 | 2,176 | 2,136 | 2,162 |
Total Common Shares Outstanding |